AIM ImmunoTech Inc (AMEX:AIM) currently has a daily average trading volume of 926.80K but it saw 5107473 shares traded in last market. With a market cap of 9.34M USD, the company’s current market price of $0.14 came rising about 9.60 while comparing to the previous closing price of $0.12. In past 52 weeks, the stock remained buoying in the range of price level as high as $0.62 and as low as $0.11.
Taking a look at 20-day trading activity of AIM ImmunoTech Inc (AIM) gives us an average price of $0.1533, while its current price level is -78.10% below from 52-week high level whereas it is 22.90% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1870 while that of 200 days or SMA-200 reads an average of $0.2841. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.86% during that period while stretching the period over a month that decreases to 14.12%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.42 which implies that the stock is in neutral territory.
Over the week, AIM’s stock price is moving 1.42% up while it is -35.05% when we observe its performance for the past one month. Year-to-date it is -31.41% down and over the past year, the stock is showing a downside performance of -67.48%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of -0.09 while estimate for next year EPS is -0.3. Moreover, analysts are in estimates of $100k for current-quarter revenue.
Currently, AIM ImmunoTech Inc’s total number of outstanding shares is 68.75M with 9.68% of that held by the insiders while 12.54% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -686.04% and return on equity (ROE) at -187.58%. Stock’s beta reads 0.42. Stock has a price to book (P/B) ratio of 2.74 while price to sale or P/S ratio amounts to 49.15. Its return on asset (ROA) is -115.46% on average.
